カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のエリスロポエチン薬市場2022年：エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他

◆英語タイトル：Global Erythropoietin Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8807）◆商品コード：GIR22MY8807
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：97
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

エリスロポエチン薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のエリスロポエチン薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

エリスロポエチン薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他

用途別セグメントは次のように区分されます。
・貧血、腎臓障害、その他

世界のエリスロポエチン薬市場の主要な市場プレーヤーは以下のとおりです。
・Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エリスロポエチン薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエリスロポエチン薬メーカーの企業概要、2019年～2022年までのエリスロポエチン薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエリスロポエチン薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別エリスロポエチン薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのエリスロポエチン薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのエリスロポエチン薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびエリスロポエチン薬の産業チェーンを掲載しています。
・第13、14、15章では、エリスロポエチン薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他
・用途別分析2017年-2028年：貧血、腎臓障害、その他
・エリスロポエチン薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・エリスロポエチン薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・エリスロポエチン薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・エリスロポエチン薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・エリスロポエチン薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Erythropoietin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Erythropoietin Drug market size is estimated to be worth US$ 8727.6 million in 2021 and is forecast to a readjusted size of USD 12730 million by 2028 with a CAGR of 5.5% during review period. Anemia accounting for % of the Erythropoietin Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Epoetin-alfa segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Erythropoietin Drug include Amgen, Johnson & Johnson, Roche, Galenica, and Emcure, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Erythropoietin Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Market segment by Application can be divided into
Anemia
Kidney Disorders
Others
The key market players for global Erythropoietin Drug market are listed below:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erythropoietin Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erythropoietin Drug, with price, sales, revenue and global market share of Erythropoietin Drug from 2019 to 2022.
Chapter 3, the Erythropoietin Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erythropoietin Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Erythropoietin Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Erythropoietin Drug.
Chapter 13, 14, and 15, to describe Erythropoietin Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Erythropoietin Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Erythropoietin Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Erythropoietin Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Global Erythropoietin Drug Market Size & Forecast
1.4.1 Global Erythropoietin Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Erythropoietin Drug Sales in Volume (2017-2028)
1.4.3 Global Erythropoietin Drug Price (2017-2028)
1.5 Global Erythropoietin Drug Production Capacity Analysis
1.5.1 Global Erythropoietin Drug Total Production Capacity (2017-2028)
1.5.2 Global Erythropoietin Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Erythropoietin Drug Market Drivers
1.6.2 Erythropoietin Drug Market Restraints
1.6.3 Erythropoietin Drug Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Erythropoietin Drug Product and Services
2.1.4 Amgen Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Erythropoietin Drug Product and Services
2.2.4 Johnson & Johnson Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Erythropoietin Drug Product and Services
2.3.4 Roche Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Galenica
2.4.1 Galenica Details
2.4.2 Galenica Major Business
2.4.3 Galenica Erythropoietin Drug Product and Services
2.4.4 Galenica Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Emcure
2.5.1 Emcure Details
2.5.2 Emcure Major Business
2.5.3 Emcure Erythropoietin Drug Product and Services
2.5.4 Emcure Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kyowa Hakko Kirin
2.6.1 Kyowa Hakko Kirin Details
2.6.2 Kyowa Hakko Kirin Major Business
2.6.3 Kyowa Hakko Kirin Erythropoietin Drug Product and Services
2.6.4 Kyowa Hakko Kirin Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 3SBio
2.7.1 3SBio Details
2.7.2 3SBio Major Business
2.7.3 3SBio Erythropoietin Drug Product and Services
2.7.4 3SBio Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business
2.8.3 Biocon Erythropoietin Drug Product and Services
2.8.4 Biocon Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 LG Life Sciences
2.9.1 LG Life Sciences Details
2.9.2 LG Life Sciences Major Business
2.9.3 LG Life Sciences Erythropoietin Drug Product and Services
2.9.4 LG Life Sciences Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Erythropoietin Drug Breakdown Data by Manufacturer
3.1 Global Erythropoietin Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Erythropoietin Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Erythropoietin Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Erythropoietin Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Erythropoietin Drug Manufacturer Market Share in 2021
3.5 Global Erythropoietin Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Erythropoietin Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Erythropoietin Drug Market Size by Region
4.1.1 Global Erythropoietin Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Erythropoietin Drug Revenue by Region (2017-2028)
4.2 North America Erythropoietin Drug Revenue (2017-2028)
4.3 Europe Erythropoietin Drug Revenue (2017-2028)
4.4 Asia-Pacific Erythropoietin Drug Revenue (2017-2028)
4.5 South America Erythropoietin Drug Revenue (2017-2028)
4.6 Middle East and Africa Erythropoietin Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Erythropoietin Drug Sales in Volume by Type (2017-2028)
5.2 Global Erythropoietin Drug Revenue by Type (2017-2028)
5.3 Global Erythropoietin Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Erythropoietin Drug Sales in Volume by Application (2017-2028)
6.2 Global Erythropoietin Drug Revenue by Application (2017-2028)
6.3 Global Erythropoietin Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Erythropoietin Drug Sales by Type (2017-2028)
7.2 North America Erythropoietin Drug Sales by Application (2017-2028)
7.3 North America Erythropoietin Drug Market Size by Country
7.3.1 North America Erythropoietin Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Erythropoietin Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Erythropoietin Drug Sales by Type (2017-2028)
8.2 Europe Erythropoietin Drug Sales by Application (2017-2028)
8.3 Europe Erythropoietin Drug Market Size by Country
8.3.1 Europe Erythropoietin Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Erythropoietin Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Erythropoietin Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Erythropoietin Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Erythropoietin Drug Market Size by Region
9.3.1 Asia-Pacific Erythropoietin Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Erythropoietin Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Erythropoietin Drug Sales by Type (2017-2028)
10.2 South America Erythropoietin Drug Sales by Application (2017-2028)
10.3 South America Erythropoietin Drug Market Size by Country
10.3.1 South America Erythropoietin Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Erythropoietin Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Erythropoietin Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Erythropoietin Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Erythropoietin Drug Market Size by Country
11.3.1 Middle East & Africa Erythropoietin Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Erythropoietin Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Erythropoietin Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Erythropoietin Drug
12.3 Erythropoietin Drug Production Process
12.4 Erythropoietin Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Erythropoietin Drug Typical Distributors
13.3 Erythropoietin Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Erythropoietin Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Erythropoietin Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Erythropoietin Drug Product and Services
Table 6. Amgen Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Erythropoietin Drug Product and Services
Table 10. Johnson & Johnson Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Erythropoietin Drug Product and Services
Table 14. Roche Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Galenica Basic Information, Manufacturing Base and Competitors
Table 16. Galenica Major Business
Table 17. Galenica Erythropoietin Drug Product and Services
Table 18. Galenica Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Emcure Basic Information, Manufacturing Base and Competitors
Table 20. Emcure Major Business
Table 21. Emcure Erythropoietin Drug Product and Services
Table 22. Emcure Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 24. Kyowa Hakko Kirin Major Business
Table 25. Kyowa Hakko Kirin Erythropoietin Drug Product and Services
Table 26. Kyowa Hakko Kirin Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. 3SBio Basic Information, Manufacturing Base and Competitors
Table 28. 3SBio Major Business
Table 29. 3SBio Erythropoietin Drug Product and Services
Table 30. 3SBio Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Biocon Basic Information, Manufacturing Base and Competitors
Table 32. Biocon Major Business
Table 33. Biocon Erythropoietin Drug Product and Services
Table 34. Biocon Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 36. LG Life Sciences Major Business
Table 37. LG Life Sciences Erythropoietin Drug Product and Services
Table 38. LG Life Sciences Erythropoietin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Erythropoietin Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Erythropoietin Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Erythropoietin Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Erythropoietin Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Erythropoietin Drug Production Site of Key Manufacturer
Table 44. Erythropoietin Drug New Entrant and Capacity Expansion Plans
Table 45. Erythropoietin Drug Mergers & Acquisitions in the Past Five Years
Table 46. Global Erythropoietin Drug Sales by Region (2017-2022) & (K Units)
Table 47. Global Erythropoietin Drug Sales by Region (2023-2028) & (K Units)
Table 48. Global Erythropoietin Drug Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Erythropoietin Drug Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
Table 51. Global Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
Table 52. Global Erythropoietin Drug Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Erythropoietin Drug Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Erythropoietin Drug Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Erythropoietin Drug Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
Table 57. Global Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
Table 58. Global Erythropoietin Drug Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Erythropoietin Drug Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Erythropoietin Drug Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Erythropoietin Drug Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Erythropoietin Drug Sales by Country (2017-2022) & (K Units)
Table 63. North America Erythropoietin Drug Sales by Country (2023-2028) & (K Units)
Table 64. North America Erythropoietin Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Erythropoietin Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
Table 67. North America Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
Table 68. North America Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
Table 69. North America Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
Table 70. Europe Erythropoietin Drug Sales by Country (2017-2022) & (K Units)
Table 71. Europe Erythropoietin Drug Sales by Country (2023-2028) & (K Units)
Table 72. Europe Erythropoietin Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Erythropoietin Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
Table 75. Europe Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
Table 76. Europe Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
Table 77. Europe Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Erythropoietin Drug Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Erythropoietin Drug Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Erythropoietin Drug Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Erythropoietin Drug Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
Table 86. South America Erythropoietin Drug Sales by Country (2017-2022) & (K Units)
Table 87. South America Erythropoietin Drug Sales by Country (2023-2028) & (K Units)
Table 88. South America Erythropoietin Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Erythropoietin Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
Table 91. South America Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
Table 92. South America Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
Table 93. South America Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Erythropoietin Drug Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Erythropoietin Drug Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Erythropoietin Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Erythropoietin Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
Table 102. Erythropoietin Drug Raw Material
Table 103. Key Manufacturers of Erythropoietin Drug Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Erythropoietin Drug Typical Distributors
Table 107. Erythropoietin Drug Typical Customers
List of Figures
Figure 1. Erythropoietin Drug Picture
Figure 2. Global Erythropoietin Drug Revenue Market Share by Type in 2021
Figure 3. Epoetin-alfa
Figure 4. Darbepoetin-alfa
Figure 5. Epoetin-beta
Figure 6. Others
Figure 7. Global Erythropoietin Drug Revenue Market Share by Application in 2021
Figure 8. Anemia
Figure 9. Kidney Disorders
Figure 10. Others
Figure 11. Global Erythropoietin Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Erythropoietin Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Erythropoietin Drug Sales (2017-2028) & (K Units)
Figure 14. Global Erythropoietin Drug Price (2017-2028) & (USD/Unit)
Figure 15. Global Erythropoietin Drug Production Capacity (2017-2028) & (K Units)
Figure 16. Global Erythropoietin Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Erythropoietin Drug Market Drivers
Figure 18. Erythropoietin Drug Market Restraints
Figure 19. Erythropoietin Drug Market Trends
Figure 20. Global Erythropoietin Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Erythropoietin Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Erythropoietin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Erythropoietin Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Erythropoietin Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Erythropoietin Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Erythropoietin Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Erythropoietin Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Erythropoietin Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Erythropoietin Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Erythropoietin Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Erythropoietin Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Erythropoietin Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Erythropoietin Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Erythropoietin Drug Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Erythropoietin Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Erythropoietin Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Erythropoietin Drug Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Erythropoietin Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Erythropoietin Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Erythropoietin Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Erythropoietin Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Erythropoietin Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Erythropoietin Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Erythropoietin Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Erythropoietin Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Erythropoietin Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Erythropoietin Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Erythropoietin Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Erythropoietin Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Erythropoietin Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Erythropoietin Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Erythropoietin Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Erythropoietin Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Erythropoietin Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Erythropoietin Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Erythropoietin Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Erythropoietin Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Erythropoietin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Erythropoietin Drug in 2021
Figure 79. Manufacturing Process Analysis of Erythropoietin Drug
Figure 80. Erythropoietin Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のエリスロポエチン薬市場2022年：エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他(Global Erythropoietin Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 短時間作用型EPO医薬品のグローバル市場展望 2023年-2029年：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他
  • 短時間作用型組換えヒトエリスロポエチン製剤のグローバル市場展望 2023年-2029年：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他
  • 短時間作用型組換えヒトエリスロポエチンのグローバル市場展望 2023年-2029年：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他
  • 長時間作用型遺伝子組換えヒトエリスロポエチン注射剤のグローバル市場展望 2023年-2029年：エポエチン-アルファ、エポエチン-ベータ、ダルベポエチン-アルファ、その他
  • 世界の遺伝性疾患薬市場2022年：嚢胞性線維症（CF）、デュシェンヌ型筋ジストロフィー（DMD）、リソソーム蓄積症（LSD）、発作性夜間ヘモグロビン尿症（PNH）